Redhill Biopharma
RDHL
#11160
Rank
A$3.77 M
Marketcap
A$0.42
Share price
-13.08%
Change (1 day)
-73.67%
Change (1 year)

Redhill Biopharma (RDHL) - Total debt

Total debt on the balance sheet as of June 2026 : A$1.62 Million

According to Redhill Biopharma's latest financial reports the company's total debt is A$1.62 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Redhill Biopharma - Total debt on balance sheet (from 2018 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$1.59 M179.11%
2024-12-31A$0.57 M-66.76%
2023-12-31A$1.72 M-99.05%
2022-12-31A$0.18 B48.85%
2021-12-31A$0.12 B7.17%
2020-12-31A$0.11 B1974.14%
2019-12-31A$5.44 M
2018-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Sanofi
SNY
A$40.65 B 2,502,969.77%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$81.44 B 5,014,411.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$47.49 B 2,924,355.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$25.49 B 1,569,574.42%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
A$2.94 M 81.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel